Advertisement
Screener

Quoin Pharmaceuticals Ltd. (QNRX) Interest Received Classified As Operating Activities

2.8 / 5 stars · 68/120 Roast Me

Quoin Pharmaceuticals Ltd. Interest Received Classified As Operating Activities

Quoin Pharmaceuticals Ltd. (QNRX) reported Interest Received Classified As Operating Activities of ILS 8.00 thousand for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-24.

Discontinued › Cash Flow › Operating Activities

ifrs-full:InterestReceivedClassifiedAsOperatingActivities · last filed 2021-08-24

ILS

Period endInterest Received Classified As Operating Activities 6 monthInterest Received Classified As Operating Activities 12 month
2021-06-308.00K ILS
6-K · filed 2021-08-24
2020-12-3164.00K ILS
20-F · filed 2021-03-29
2020-06-3035.00K ILS
6-K · filed 2021-08-24
2019-12-3193.00K ILS
20-F · filed 2021-03-29
2018-12-3154.00K ILS
20-F · filed 2021-03-29
2017-12-31147.00K ILS
20-F · filed 2020-04-03
2015-12-311.00K ILS
20-F · filed 2018-03-19

USD

Period endInterest Received Classified As Operating Activities 6 monthInterest Received Classified As Operating Activities 12 month
2021-06-30$3.00K
6-K · filed 2021-08-24
2020-12-31$20.00K
20-F · filed 2021-03-29
2019-12-31$27.00K
20-F · filed 2020-04-03
2017-12-31$42.00K
20-F · filed 2018-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05